Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells

被引:29
|
作者
Lundberg, P
Lerner, UH [1 ]
机构
[1] Umea Univ, Dept Oral Cell BIol, S-90187 Umea, Sweden
[2] Natl Inst Working Life, Ctr Musculoskeletal Res, Umea, Sweden
关键词
VIP; osteoblasts; osteoclasts; bone resorption; bone formation;
D O I
10.1002/jemt.10124
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
An intense network of nerve fibers can be demonstrated in skeletal tissues, not only in the periosteum but also within cortical bone, growth plate, and bone marrow. This neuro-osteogenic network expresses a restricted number of signalling molecules, including neuropeptides, neurotransmitters, and neurotrophins. Several lines of evidence indicate that receptors for these molecules are present on bone cells and that activation of these receptors leads to changes in bone cell activities. In addition, deletion of signalling molecules has been shown to alter bone metabolism. In the present review, these studies are summarized with a focus on distribution and effects of vasoactive intestinal peptide. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 50 条
  • [41] Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP)
    Haidan, A
    Hilbers, U
    Bornstein, SR
    Ehrhart-Bornstein, M
    PEPTIDES, 1998, 19 (09) : 1511 - 1517
  • [42] Pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptide receptor expression in immortalized LHRH neurons
    Olcese, J
    McArdle, CA
    Middendorff, R
    Greenland, K
    JOURNAL OF NEUROENDOCRINOLOGY, 1997, 9 (12) : 937 - 943
  • [43] Identification of secretin, vasoactive intestinal peptide and glucagon binding sites: from chimaeric receptors to point mutations
    Waelbroeck, M
    Perret, J
    Vertongen, P
    Van Craenenbroeck, M
    Robberecht, P
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 437 - 441
  • [44] Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats
    Kalló, I
    Kalamatianos, T
    Piggins, HD
    Coen, CW
    JOURNAL OF NEUROENDOCRINOLOGY, 2004, 16 (09) : 758 - 766
  • [45] Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer:: Antagonistic action of a growth-hormone-releasing hormone analog
    Collado, B
    Carmena, MJ
    Sánchez-Chapado, M
    Ruíz-Villaespesa, A
    Bajo, AM
    Fernández-Martínez, AB
    Varga, JL
    Schally, AV
    Prieto, JC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (06) : 1629 - 1635
  • [46] Vasoactive Intestinal Peptide-Mediated Th17 Differentiation An Expanding Spectrum of Vasoactive Intestinal Peptide Effects in Immunity and Autoimmunity
    Yadav, Mahesh
    Goetzl, Edward J.
    Neural Signaling: Opportunities for Novel Diagnostic Approaches and Therapies, 2008, 1144 : 83 - 89
  • [47] Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells
    Juarranz, MG
    Santiago, B
    Torroba, M
    Gutierrez-Cañas, I
    Palao, G
    Galindo, M
    Abad, C
    Martinez, C
    Leceta, J
    Pablos, JL
    Gomariz, RP
    RHEUMATOLOGY, 2004, 43 (04) : 416 - 422
  • [48] Antioxidant activity of vasoactive intestinal peptide in HK2 human renal cells
    Vacas, Eva
    Bajo, Ana M.
    Schally, Andrew V.
    Sanchez-Chapado, Manuel
    Prieto, Juan C.
    Carmena, Maria J.
    PEPTIDES, 2012, 38 (02) : 275 - 281
  • [49] Activation of CFTR Trafficking and Gating by Vasoactive Intestinal Peptide in Human Bronchial Epithelial Cells
    Qu, Fei
    Liu, Hui-Jun
    Xiang, Yang
    Tan, Yu-Rong
    Liu, Chi
    Zhu, Xiao-Lin
    Qin, Xiao-Qun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (03) : 902 - 908
  • [50] Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells
    Collado, B
    Gutiérrez-Cañas, I
    Rodríguez-Henche, N
    Prieto, JC
    Carmena, MJ
    REGULATORY PEPTIDES, 2004, 119 (1-2) : 69 - 75